L’Oréal Signs Development Deal for Biotech Ingredients

L’Oréal has signed an agreement with Debut, a San Diego-based vertically integrated biotechnology company, to develop more than a dozen bio-identical ingredients that will replace conventionally sourced ingredients currently used in skin, hair, color cosmetics and fragrance formulas.

As part of the accord, Debut says it will create new bio-based ingredients using its proprietary advanced biomanufacturing processes.

“Through this exciting partnership and adoption of breakthrough technology, we are well-positioned to drive the creation of more sustainable and effective products that meet the demands of our consumers and fulfils our duty of care for the planet,” said Guive Balooch, global managing director of augmented beauty and open innovation at L’Oréal Groupe. “This long-term agreement with Debut is another example of our commitment to the Open Innovation ecosystem and building the future of beauty by collaborating with best-in-class partners.”

“Creating bio-identical ingredients at scale helps preserve global biodiversity and secure responsible ingredient supply chains while continuing to prioritize quality and product performance,” said Debut Founder and CEO Joshua Britton, Ph.D. “Debut is committed to creating bio-based formulations for all its beauty products and has unmatched capabilities in biotechnology, formulation and scaling to catalyze this transformative shift in beauty.”